Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan

Modeling the budget impact of long-acting injectable paliperidone palmitate in the treatment of schizophrenia in Japan

Jörg Mahlich,1,2 Masamichi Nishi,3 Yoshimichi Saito11Health Economics, Janssen Pharmaceutical KK, Tokyo, Japan; 2Düsseldorf Institute for Competition Economics, University of Düsseldorf, Düsseldorf, Germany; 3Pricing, Janssen Pharmaceutical KK, Tokyo, JapanBackgro...

Full description

Bibliographic Details
Main Authors: Mahlich J, Nishi M, Saito Y
Format: Article
Language:English
Published: Dove Medical Press 2015-05-01
Series:ClinicoEconomics and Outcomes Research
Online Access:http://www.dovepress.com/modeling-the-budget-impact-of-long-acting-injectable-paliperidone-palm-peer-reviewed-article-CEOR

Internet

http://www.dovepress.com/modeling-the-budget-impact-of-long-acting-injectable-paliperidone-palm-peer-reviewed-article-CEOR

Similar Items